{"entity":{"id":"aarhus-university-hospital","kind":"institution","name":"Aarhus University Hospital","aka":["AUH","Danish Centre for Particle Therapy"],"tldr":"Aarhus University Hospital hosts the Danish Centre for Particle Therapy, the national proton facility opened in 2019; its oncology department under Jens Overgaard has run the DAHANCA head and neck trials that established accelerated fractionation and the radiosensitiser nimorazole.","summary":"Aarhus University Hospital hosts the Danish Centre for Particle Therapy, the country's national proton facility, which opened in 2019 with Varian ProBeam gantries and treats patients from across Denmark within randomised trials. Its experimental clinical oncology department under Jens Overgaard has run the DAHANCA head and neck cancer trials for decades, establishing accelerated fractionation and the hypoxic radiosensitiser nimorazole, and pioneered clinical hyperthermia with radiotherapy for melanoma. The hospital is a major transplant, urological cancer and gastrointestinal surgery centre, contributes to Danish Breast Cancer Group trials, and leads registry-based studies through Aarhus University's clinical epidemiology department.","asOf":"2026-09-09","wikipedia":"https://en.wikipedia.org/wiki/Aarhus_University_Hospital","links":[{"label":"Homepage","url":"https://www.en.auh.dk"},{"label":"PTCOG: particle therapy facilities in operation","url":"https://www.ptcog.site/index.php/facilities-in-operation-public"}],"tags":[],"related":[],"cancers":["head-and-neck","prostate","melanoma","breast-hr-positive"],"sections":["radiation"],"technologies":["proton-therapy","imrt-igrt","hyperthermia","sbrt","proton-therapy-systems"],"targets":[],"drugs":[],"companies":["varian"],"institutions":["rigshospitalet"],"pathways":[],"terms":[],"trials":[],"people":["thomas-balle-kristensen","jens-overgaard"],"bottlenecks":["b-surgery-radiation-innovation"],"keyPapers":[],"journals":[],"dependsOn":[],"notes":[],"city":"Aarhus","country":"DK","lat":56.194,"lng":10.19,"institutionType":"hospital","website":"https://www.en.auh.dk","university":"Aarhus University","programs":["Danish Centre for Particle Therapy","DAHANCA head and neck trials","Hyperthermia and radiobiology","Clinical epidemiology","Urological oncology"]},"route":"/institutions/aarhus-university-hospital/","neighbours":{"cancer":[{"id":"head-and-neck","kind":"cancer","name":"Head and neck squamous cell carcinoma","route":"/cancers/head-and-neck/"},{"id":"breast-hr-positive","kind":"cancer","name":"HR-positive / HER2-negative breast cancer","route":"/cancers/breast-hr-positive/"},{"id":"melanoma","kind":"cancer","name":"Melanoma","route":"/cancers/melanoma/"},{"id":"prostate","kind":"cancer","name":"Prostate cancer","route":"/cancers/prostate/"}],"section":[{"id":"radiation","kind":"section","name":"Radiation Therapy","route":"/fronts/radiation/"}],"technology":[{"id":"hyperthermia","kind":"technology","name":"Hyperthermia","route":"/technologies/hyperthermia/"},{"id":"imrt-igrt","kind":"technology","name":"IMRT / IGRT (modern external beam)","route":"/technologies/imrt-igrt/"},{"id":"proton-therapy","kind":"technology","name":"Proton therapy","route":"/technologies/proton-therapy/"},{"id":"proton-therapy-systems","kind":"technology","name":"Proton therapy machines: cyclotrons, synchrotrons and single-room systems","route":"/technologies/proton-therapy-systems/"},{"id":"sbrt","kind":"technology","name":"SBRT / SABR (stereotactic radiotherapy)","route":"/technologies/sbrt/"}],"company":[{"id":"varian","kind":"company","name":"Varian (Siemens Healthineers)","route":"/companies/varian/"}],"institution":[{"id":"aalborg-university-hospital","kind":"institution","name":"Aalborg University Hospital","route":"/institutions/aalborg-university-hospital/"},{"id":"odense-university-hospital","kind":"institution","name":"Odense University Hospital","route":"/institutions/odense-university-hospital/"},{"id":"rigshospitalet","kind":"institution","name":"Rigshospitalet, Copenhagen University Hospital","route":"/institutions/rigshospitalet/"}],"person":[{"id":"jens-overgaard","kind":"person","name":"Jens Overgaard","route":"/people/jens-overgaard/"},{"id":"thomas-balle-kristensen","kind":"person","name":"Thomas Balle Kristensen","route":"/people/thomas-balle-kristensen/"}],"bottleneck":[{"id":"b-surgery-radiation-innovation","kind":"bottleneck","name":"Surgery and radiotherapy cure most, get least","route":"/bottlenecks/b-surgery-radiation-innovation/"}],"paper":[{"id":"paper-reinert-ctdna-ultradeep-sequencing-colorectal-jama-oncol-2019","kind":"paper","name":"Analysis of plasma cell-free DNA by ultradeep sequencing in patients with stages I to III colorectal cancer","route":"/key-papers/paper-reinert-ctdna-ultradeep-sequencing-colorectal-jama-oncol-2019/"},{"id":"paper-henriksen-ctdna-stage-iii-colorectal-improve-it-ccr-2022","kind":"paper","name":"Circulating tumor DNA in stage III colorectal cancer, beyond minimal residual disease detection, toward assessment of adjuvant therapy efficacy and clinical behavior of recurrences","route":"/key-papers/paper-henriksen-ctdna-stage-iii-colorectal-improve-it-ccr-2022/"}]}}